CLEO Strengthens FDA Submission - Access to US Biobank
Filed with ASX · · 4 pages · English
Story so far
Earlier from CLEO Diagnostics
- Corporate Presentation
- Cleo Advances with Completion of Alpha Testing
- CLEO to Fast Track Development of Ovarian Cancer Test
- CLEO Receives A$845k Research and Development Tax Incentive
- CLEO Delivers Commercial Development Milestone
Later from CLEO Diagnostics
- COV Commences Health Economic Study-Support US Market Entry
- Appendix 4E and 2025 Annual Report
- Cleo Receives Positive FDA Feedback
- CLEO Successfully Completes Stage 1 MDSAP Audit
- CLEO Significantly Expands Addressable Market
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics